Related references
Note: Only part of the references are listed.The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: A national cross sectional study
Jo-Anne E. Manski-Nankervis et al.
PRIMARY CARE DIABETES (2019)
Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
Yao Qiao et al.
MAYO CLINIC PROCEEDINGS (2019)
Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report
Sree K. Venuthurupalli et al.
NEPHROLOGY (2019)
Epidemiology of chronic kidney disease in Australian general practice: National Prescribing Service MedicineWise MedicineInsight dataset
Janette Radford et al.
NEPHROLOGY (2019)
Epidemiology of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies and rheumatoid arthritis among 1.5 million patients in Australian general practice: NPS MedicineWise MedicineInsight dataset
David Alejandro Gonzalez-Chica et al.
BMC MUSCULOSKELETAL DISORDERS (2018)
Medication Safety Principles and Practice in CKD
Chanel F. Whittaker et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Why do the Media report negative news about statins? A personal viewpoint by Dr Borge G. Nordestgaard with review of results from a huge survey in Denmark of more than 500 000 people on statins from the Danish population
Borge G. Nordestgaard
EUROPEAN HEART JOURNAL (2018)
Continuity of care with doctors - a matter of life and death? A systematic review of continuity of care and mortality
Denis J. Pereira Gray et al.
BMJ OPEN (2018)
Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study
Katrina Hui et al.
BMC NEPHROLOGY (2017)
Lipid lowering in renal disease
Alice Kennard et al.
AUSTRALIAN PRESCRIBER (2017)
Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program
Svetla Gadzhanova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Potentially inappropriate medication prescribing is associated with socioeconomic factors: a spatial analysis in the French Nord-Pas-de-Calais Region
Jean-Baptiste Beuscart et al.
AGE AND AGEING (2017)
A Population-Based Analysis of Quality Indicators in CKD
Liam Manns et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician
Joseph A. Vassalotti et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Continuity of care in primary care and association with survival in older people: a 17-year prospective cohort study
Otto R. Maarsingh et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2016)
Measuring Care Continuity A Comparison of Claims-based Methods
Craig E. Pollack et al.
MEDICAL CARE (2016)
Development and initial validation of prescribing quality indicators for patients with chronic kidney disease
Kirsten P. J. Smits et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Aimun Ahmed et al.
NEPHRON (2016)
Retrospective evaluation of potentially inappropriate prescribing in hospitalized patients with renal impairment
Hannah K. Doody et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Prevalence and management of chronic kidney disease in primary care patients in the UK
K. Jameson et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
Christoph Wanner et al.
KIDNEY INTERNATIONAL (2014)
Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
David C. Wheeler et al.
KIDNEY INTERNATIONAL (2013)
Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study
Francesco Lapi et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)
Mona Razavian et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement
David W. Johnson et al.
MEDICAL JOURNAL OF AUSTRALIA (2012)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
Influence of socioeconomic status on the quality of prescribing in the elderly - a population based study
E Odubanjo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)